A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
for Colitis Ulcerative
Drug: MK-8690
9 locations incl. Anaheim
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18 - 75
Code: NCT07463183·Phase 2·Recruiting